Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

APOL

Apollon Formularies (APOL)

Apollon Formularies plc
일자:
정렬 기준:
 검색 관련기사 보기:AQSE:APOL
일자시간출처헤드라인심볼기업
2024/05/0320:59UK RegulatoryApollon Formularies Plc - Notice of GMAQSE:APOLApollon Formularies plc
2024/05/0123:00UK RegulatoryApollon Formularies Plc - Intention to Withdraw from AQUISAQSE:APOLApollon Formularies plc
2024/02/2019:59UK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
2024/01/0217:18UK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
2023/12/0520:59UK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
2023/11/2120:51UK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
2023/09/2915:00UK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
2023/09/1917:18UK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
2023/08/0318:51UK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
2023/08/0220:19UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
2023/07/2419:00UK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
2023/07/0101:32UK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
2023/05/1101:05UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
2023/04/1122:00UK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
2023/03/2121:00UK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
2023/03/1516:00UK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
2023/01/1216:00UK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
2022/12/3021:37UK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
2022/12/0216:00UK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
2022/09/3017:50UK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
2022/09/1315:02UK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
2022/08/0217:11UK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
2022/07/2615:00UK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
2022/07/0100:29UK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
2022/06/3020:33UK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
2022/06/1721:23UK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
2022/05/0520:07UK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
2022/03/0216:01UK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
2022/02/0916:00UK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
2022/02/0315:59UK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
 검색 관련기사 보기:AQSE:APOL

최근 히스토리

Delayed Upgrade Clock